Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NICE
Pharma
Orchard nabs approval for first MLD gene therapy in US
The FDA gave a thumbs up to Lenmeldy as the first gene therapy in the U.S. for kids with certain types of metachromatic leukodystrophy (MLD).
Fraiser Kansteiner
Mar 18, 2024 3:25pm
NICE rejects Vertex, CRISPR's Casgevy, asks for more data
Mar 14, 2024 11:24am
Regulatory tracker: J&J, Pfizer, Daiichi Sankyo, MHRA and more
Mar 12, 2024 11:20am
NICE reverses its call on Talzenna after Pfizer discount
Jan 19, 2024 7:47am
Regulatory tracker: Merck, Biogen and more
Dec 19, 2023 8:40am
In 'historic' nod, UK signs off on Vertex, CRISPR's gene therapy
Nov 16, 2023 11:45am